CMV-, EBV- and ADV-Specific T Cell Immunity: Screening and Monitoring of Potential Third-Party Donors to Improve Post-Transplantation Outcome-Reference-Cited by-同舟云学术

CMV-, EBV- and ADV-Specific T Cell Immunity: Screening and Monitoring of Potential Third-Party Donors to Improve Post-Transplantation Outcome

Published:2013-10 Issue:10 Volume:19 Page:1480-1492
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Sukdolak Cinja,Tischer Sabine,Dieks Daria,Figueiredo Constanca,Goudeva Lilia,Heuft Hans-Gert,Verboom Murielle,Immenschuh Stephan,Heim Albert,Borchers Sylvia,Mischak-Weissinger Eva,Blasczyk Rainer,Maecker-Kolhoff Britta,Eiz-Vesper Britta

Funder

German Federal Ministry of Education and Research

German Children's Cancer Research Fund (Deutsche Kinderkrebshilfe)

Immunotherapy Foundation (Stiftung Immuntherapie)

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference56 articles.

1. Reduced mortality after allogeneic hematopoietic-cell transplantation;Gooley;N Engl J Med,2010

2. Life-threatening adenovirus infections in the setting of the immunocompromised allogeneic stem cell transplant patients;Fowler;Adv Hematol,2010

3. Clinical aspects of CMV infection after stem cell transplantation;Hebart;Hum Immunol,2004

4. Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation;Lucas;Blood,1998

5. Generation of HCMV-specific T cell lines from seropositive solid-organ-transplant recipients for adoptive T cell therapy;Brestrich;J Immunother,2009

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineered HCMV‐infected APCs enable the identification of new immunodominant HLA‐restricted epitopes of anti‐HCMV T‐cell immunity;HLA;2024-06

2. Stealth transgenes enable CAR-T cells to evade host immune responses;Journal for ImmunoTherapy of Cancer;2024-05

3. Development and characterization of a cell donor registry for virus‐specific T cell manufacture in a blood bank;HLA;2024-03

4. Identification of novel canonical and cryptic HCMV-specific T-cell epitopes for HLA-A*03 and HLA-B*15 via peptide-PRISM;Blood Advances;2023-12-21

5. DNA methylation profiling identifies TBKBP1 as potent amplifier of cytotoxic activity in CMV-specific human CD8⁺T cells;2023-11-06